Grigory Ryzhakov
Oxford, ENG OX37FY, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.
Journal: Nature communications
Published: June 14, 2020
Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis.
Journal: Nature communications
Published: April 25, 2018
Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Journal: Nature medicine
Published: June 07, 2017
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Journal: Nature medicine
Published: December 23, 2016
Activation and function of interferon regulatory factor 5.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: September 27, 2014
Cross-species analysis reveals evolving and conserved features of the nuclear factor κB (NF-κB) proteins.
Journal: The Journal of biological chemistry
Published: March 20, 2013
IL-17 receptor adaptor protein Act1/CIKS plays an evolutionarily conserved role in antiviral signaling.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 16, 2012
KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages.
Journal: Immunobiology
Published: April 24, 2012
IL-17 boosts proinflammatory outcome of antiviral response in human cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 04, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026